Older Adults With Severe, Treatment-Resistant Depression

被引:31
|
作者
Unuetzer, Juergen [1 ,2 ]
Park, Mijung [3 ]
机构
[1] Univ Washington, Ctr Med, UW AIMS Ctr, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[2] Univ Washington, Ctr Med, IMPACT Implementat Program, Seattle, WA 98195 USA
[3] Univ Pittsburgh, Dept Hlth & Community Syst, Pittsburgh, PA USA
来源
关键词
LATE-LIFE DEPRESSION; BEHAVIORAL ACTIVATION TREATMENTS; PRIMARY-CARE PATIENTS; ELECTROCONVULSIVE-THERAPY; MAJOR DEPRESSION; COLLABORATIVE CARE; 2ND-GENERATION ANTIDEPRESSANTS; INTERPERSONAL PSYCHOTHERAPY; SOMATIC SYMPTOMS; ELDERLY-PATIENTS;
D O I
10.1001/2012.jama.10690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depression is a common, disabling, and costly condition encountered in older patients. Effective strategies for detection and treatment of late-life depression are summarized based on a case of a 69-year-old woman who struggled with prolonged depression. Clinicians should screen older patients for depression using a standard rating scale, initiate treatment such as antidepressant medications or evidence-based psychotherapy, and monitor depression symptoms. Patients who are not improving should be considered for psychiatric consultation and treatment changes including electroconvulsive therapy. Several changes in treatment approaches are usually needed before patients achieve complete remission. Maintenance treatment and relapse-prevention planning (summarization of early warning signs for depression, maintenance treatments such as medications, and other strategies to reduce the risk of relapse [eg, regular physical activity or pleasant activities]) can reduce the risk of relapse. Collaborative programs, in which primary care clinicians work closely with mental health specialists following a measurement-based treatment-to-target approach, are significantly more effective than typical primary care treatment. JAMA. 2012;308(9):909-918
引用
收藏
页码:909 / 918
页数:10
相关论文
共 50 条
  • [41] Management of Treatment-Resistant Depression
    Keitner, Gabor I.
    Mansfield, Abigail K.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 35 (01) : 249 - +
  • [42] Treatment-Resistant Depression: An Overview
    Moukaddam, Nidal
    Shah, Asim A.
    PSYCHIATRIC ANNALS, 2016, 46 (04) : 224 - 229
  • [43] Psilocybin in Treatment-Resistant Depression
    Madras, Bertha K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (18): : 1708 - 1709
  • [44] Psychotherapy and Treatment-Resistant Depression
    Parks, Kimberly
    Wojcik, Katharine D.
    Blassingame, Jonathan C., III
    PSYCHIATRIC ANNALS, 2024, 54 (06) : e182 - e185
  • [45] Inflammatory predictors of response to intensive inpatient treatment in severe treatment-resistant depression
    Strawbridge, R.
    Powell, T. R.
    Breen, G.
    Young, A. H.
    Cleare, A. J.
    BIPOLAR DISORDERS, 2016, 18 : 144 - 145
  • [46] DBS IN TREATMENT-RESISTANT DEPRESSION
    Delimpalta, C.
    Zampetaki, C.
    Varouchaki, E.
    Zampogiannis, A.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [47] CHALLENGES OF TREATMENT-RESISTANT DEPRESSION
    Pandarakalam, James Paul
    PSYCHIATRIA DANUBINA, 2018, 30 (03) : 273 - 284
  • [48] Treatment-resistant depression - Preface
    HornigRohan, M
    Amsterdam, JD
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1996, 19 (02) : R11 - R12
  • [49] Defining Treatment-Resistant Depression
    Fogelson, David L.
    Leuchter, Andrew
    JAMA PSYCHIATRY, 2017, 74 (07) : 758 - +
  • [50] Augmentation in treatment-resistant depression
    McIntyre, J.
    Moral, Ma Angels
    DRUGS OF THE FUTURE, 2006, 31 (12) : 1069 - 1081